During the past decade, Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Grifols Therapeutics LLC" with 2 trials sponsored, "National Institute for Tuberculosis and Lung Diseases, Poland" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Corbus Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" #1 collaborator was "Healthup Sp. z o.o." with 1 trials as a collaborator and "Medical University of Warsaw" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Asthma" (1 trials), "Autoimmune Pulmonary Alveolar Proteinosis" (1 trials), "COPD" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" in a lesser frequency.

Most popular intervention types in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" are "Drug" (9 trials), "Biological" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Alpha-1 MP" (2 trials), "Pirfenidone" (2 trials), "0.9% Sodium Chloride for Injection, USP" (1 trials) and "AioCare" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".